huathuatkia的个人主页 - 老虎社区

huathuatkia

暂无个人介绍

IP属地：未知

4关注

1粉丝

0主题

0勋章

2021-06-12

Kk

Move Over, AMC and Dogecoin -- This Stock Could Be a Much Bigger Long-Term Winner

2021-06-12

Nice

抱歉，原内容已删除

2021-06-12

Ok

15 momentum stocks expected to show the best sales growth over the next two years, including Carvana, Tesla and Palantir

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3581987733859257","uuid":"3581987733859257","gmtCreate":1618893709500,"gmtModify":1618893709500,"name":"huathuatkia","pinyin":"huathuatkia","introduction":"","introductionEn":"","signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":1,"headSize":4,"tweetSize":3,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":0,"name":"","nameTw":"","represent":"","factor":"","iconColor":"","bgColor":""},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"228c86a078844d74991fff2b7ab2428d-3","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资合伙人虎","description":"证券账户累计交易金额达到100万美元","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"93.34%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.09.03","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"35ec162348d5460f88c959321e554969-2","templateUuid":"35ec162348d5460f88c959321e554969","name":"宗师交易员","description":"证券或期货账户累计交易次数达到100次","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.05.06","exceedPercentage":"80.27%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.03.20","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":3,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":186531655,"gmtCreate":1623508933577,"gmtModify":1634032257901,"author":{"id":"3581987733859257","authorId":"3581987733859257","name":"huathuatkia","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581987733859257","idStr":"3581987733859257"},"themes":[],"htmlText":"Kk","listText":"Kk","text":"Kk","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/186531655","repostId":"2142270837","repostType":4,"repost":{"id":"2142270837","kind":"highlight","pubTimestamp":1623424800,"share":"https://www.laohu8.com/m/news/2142270837?lang=&edition=full","pubTime":"2021-06-11 23:20","market":"us","language":"en","title":"Move Over, AMC and Dogecoin -- This Stock Could Be a Much Bigger Long-Term Winner","url":"https://stock-news.laohu8.com/highlight/detail?id=2142270837","media":"Motley Fool","summary":"It has a key advantage that should make a huge difference over the next 10 or more years.","content":"<p>You won't find hotter stars in the investing universe so far this year than&nbsp;<b>AMC Entertainment</b> (NYSE:AMC) and <b>Dogecoin</b> (CRYPTO:DOGE). Retail investors have jumped aboard their bandwagons in force. AMC's shares have vaulted more than 2,300% higher year to date, while the price of Dogecoin has skyrocketed over 5,600%.</p>\n<p>The big question for AMC and Dogecoin is whether or not their momentum is sustainable. There's considerable disagreement about the right answer to that question.</p>\n<p>Probably the better question to ask, though, is whether or not there are other investment alternatives that provide better risk-reward propositions over the next 10 years or more. My view is that the answer to this question is a resounding \"yes.\"</p>\n<p>Move over AMC and Dogecoin: Here's a stock that could be a bigger long-term winner.</p>\n<p><img src=\"https://static.tigerbbs.com/60aa704652c60d9c305da0999c714b57\" tg-width=\"700\" tg-height=\"525\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: Getty Images.</p>\n<h2>A big advantage for a big biotech</h2>\n<p>The stock I have in mind is none other than&nbsp;<b>Vertex Pharmaceuticals</b> (NASDAQ:VRTX). Granted, Vertex hasn't delivered anywhere close to the kinds of returns that AMC and Dogecoin have in recent months. It even just reported a setback for <a href=\"https://laohu8.com/S/AONE\">one</a> of its pipeline candidates. However, this big biotech holds an advantage over both of them that should make a huge difference over the long run: Vertex enjoys a monopoly in its core market.</p>\n<p>There are currently four approved drugs in the U.S. and Europe that treat the underlying cause of rare genetic disease cystic fibrosis (CF), and Vertex markets all of them. Its newest CF drug, Trikafta/Kaftrio, is its biggest winner yet. The drug is just beginning to pick up momentum in Europe.</p>\n<p>What about potential rivals? <a href=\"https://laohu8.com/S/TWOA.U\">Two</a> other companies have clinical-stage candidates that target the underlying cause of CF. However, those experimental drugs are only in phase 2 testing, and there's no guarantee the candidates will be more effective than Vertex's products that are already on the market. Vertex seems likely to dominate the CF market, at least through the next decade.</p>\n<p>Let's compare Vertex's monopoly to the competitive dynamics for AMC and Dogecoin. AMC isn't the only theater chain. Its top rivals include <b>Cineplex</b>, <b>Cinemark</b>, <b>Marcus</b>, and Regal Entertainment. Streaming services that allow people to watch new movies at home are also a competitive threat to AMC.</p>\n<p>Dogecoin isn't the only cryptocurrency vying for investors' favor, either. There are other cryptocurrencies that seem even more likely to succeed over the next several years than Dogecoin.</p>\n<p>The bottom line is that Vertex has a moat, while AMC and Dogecoin don't. Over the long run, moats matter.</p>\n<h2>Looking to the future</h2>\n<p>Dogecoin likely has a hit-or-miss future. It either will become a top cryptocurrency that enjoys enduring use or it will fade away.</p>\n<p>On the other hand, AMC will probably experience a solid rebound as life returns to normal with fears about the COVID-19 pandemic waning. That should boost the company's sales this year and into 2022. But how long can AMC's growth story last? Movie-theater attendance was declining somewhat even before the pandemic. It won't be surprising to see that trend resume after an initial resurgence.</p>\n<p>Meanwhile, Vertex continues to focus on treating the remaining 10% of CF patients that its current drugs can't help. The company is also developing experimental therapies for other rare diseases, including alpha-1 antitrypsin deficiency, APOL1-mediated kidney diseases, beta-thalassemia, Duchenne muscular dystrophy, and sickle cell disease.</p>\n<p>Vertex isn't limiting itself to just rare diseases, though. It's testing an experimental drug for the treatment of acute pain following certain types of surgeries in phase 2 clinical trials. The biotech is evaluating a gene therapy in a phase 1/2 study that holds the potential to essentially cure type 1 diabetes</p>\n<p>The important thing to note is that Vertex doesn't need all of these programs to be successful. If only <a href=\"https://laohu8.com/S/AONE.U\">one</a> or two of them pan out, this biotech stock should deliver tremendous returns.</p>\n<h2>Beyond the hype</h2>\n<p>I think it's quite possible that AMC and/or Dogecoin will outperform Vertex over the short term. If you're a short-term trader looking to capture quick profits, that's great. However, my focus from the beginning has been on the long term.</p>\n<p>Sooner or later, the hype for AMC and Dogecoin will die down. What happens then? Short-term traders will turn to another stock or cryptocurrency to ride.</p>\n<p>Vertex, though, is working every single day to treat and even cure diseases that cause suffering for many people around the world. Its CF franchise is generating billions of dollars in sales every year, and the company is using its growing cash stockpile to fund further development and make more deals to bolster its pipeline.</p>\n<p>My view is that these continuous efforts will make Vertex a bigger winner than either AMC or Dogecoin over the long term.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Move Over, AMC and Dogecoin -- This Stock Could Be a Much Bigger Long-Term Winner</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMove Over, AMC and Dogecoin -- This Stock Could Be a Much Bigger Long-Term Winner\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-11 23:20 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/11/move-over-amc-and-dogecoin-this-stock-could-be-a-m/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>You won't find hotter stars in the investing universe so far this year than AMC Entertainment (NYSE:AMC) and Dogecoin (CRYPTO:DOGE). Retail investors have jumped aboard their bandwagons in force. AMC'...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/11/move-over-amc-and-dogecoin-this-stock-could-be-a-m/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VERX":"Vertex, Inc."},"source_url":"https://www.fool.com/investing/2021/06/11/move-over-amc-and-dogecoin-this-stock-could-be-a-m/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2142270837","content_text":"You won't find hotter stars in the investing universe so far this year than AMC Entertainment (NYSE:AMC) and Dogecoin (CRYPTO:DOGE). Retail investors have jumped aboard their bandwagons in force. AMC's shares have vaulted more than 2,300% higher year to date, while the price of Dogecoin has skyrocketed over 5,600%.\nThe big question for AMC and Dogecoin is whether or not their momentum is sustainable. There's considerable disagreement about the right answer to that question.\nProbably the better question to ask, though, is whether or not there are other investment alternatives that provide better risk-reward propositions over the next 10 years or more. My view is that the answer to this question is a resounding \"yes.\"\nMove over AMC and Dogecoin: Here's a stock that could be a bigger long-term winner.\n\nImage source: Getty Images.\nA big advantage for a big biotech\nThe stock I have in mind is none other than Vertex Pharmaceuticals (NASDAQ:VRTX). Granted, Vertex hasn't delivered anywhere close to the kinds of returns that AMC and Dogecoin have in recent months. It even just reported a setback for one of its pipeline candidates. However, this big biotech holds an advantage over both of them that should make a huge difference over the long run: Vertex enjoys a monopoly in its core market.\nThere are currently four approved drugs in the U.S. and Europe that treat the underlying cause of rare genetic disease cystic fibrosis (CF), and Vertex markets all of them. Its newest CF drug, Trikafta/Kaftrio, is its biggest winner yet. The drug is just beginning to pick up momentum in Europe.\nWhat about potential rivals? Two other companies have clinical-stage candidates that target the underlying cause of CF. However, those experimental drugs are only in phase 2 testing, and there's no guarantee the candidates will be more effective than Vertex's products that are already on the market. Vertex seems likely to dominate the CF market, at least through the next decade.\nLet's compare Vertex's monopoly to the competitive dynamics for AMC and Dogecoin. AMC isn't the only theater chain. Its top rivals include Cineplex, Cinemark, Marcus, and Regal Entertainment. Streaming services that allow people to watch new movies at home are also a competitive threat to AMC.\nDogecoin isn't the only cryptocurrency vying for investors' favor, either. There are other cryptocurrencies that seem even more likely to succeed over the next several years than Dogecoin.\nThe bottom line is that Vertex has a moat, while AMC and Dogecoin don't. Over the long run, moats matter.\nLooking to the future\nDogecoin likely has a hit-or-miss future. It either will become a top cryptocurrency that enjoys enduring use or it will fade away.\nOn the other hand, AMC will probably experience a solid rebound as life returns to normal with fears about the COVID-19 pandemic waning. That should boost the company's sales this year and into 2022. But how long can AMC's growth story last? Movie-theater attendance was declining somewhat even before the pandemic. It won't be surprising to see that trend resume after an initial resurgence.\nMeanwhile, Vertex continues to focus on treating the remaining 10% of CF patients that its current drugs can't help. The company is also developing experimental therapies for other rare diseases, including alpha-1 antitrypsin deficiency, APOL1-mediated kidney diseases, beta-thalassemia, Duchenne muscular dystrophy, and sickle cell disease.\nVertex isn't limiting itself to just rare diseases, though. It's testing an experimental drug for the treatment of acute pain following certain types of surgeries in phase 2 clinical trials. The biotech is evaluating a gene therapy in a phase 1/2 study that holds the potential to essentially cure type 1 diabetes\nThe important thing to note is that Vertex doesn't need all of these programs to be successful. If only one or two of them pan out, this biotech stock should deliver tremendous returns.\nBeyond the hype\nI think it's quite possible that AMC and/or Dogecoin will outperform Vertex over the short term. If you're a short-term trader looking to capture quick profits, that's great. However, my focus from the beginning has been on the long term.\nSooner or later, the hype for AMC and Dogecoin will die down. What happens then? Short-term traders will turn to another stock or cryptocurrency to ride.\nVertex, though, is working every single day to treat and even cure diseases that cause suffering for many people around the world. Its CF franchise is generating billions of dollars in sales every year, and the company is using its growing cash stockpile to fund further development and make more deals to bolster its pipeline.\nMy view is that these continuous efforts will make Vertex a bigger winner than either AMC or Dogecoin over the long term.","news_type":1},"isVote":1,"tweetType":1,"viewCount":388,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":186594506,"gmtCreate":1623508389905,"gmtModify":1634032261881,"author":{"id":"3581987733859257","authorId":"3581987733859257","name":"huathuatkia","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581987733859257","idStr":"3581987733859257"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/186594506","repostId":"1124998394","repostType":4,"isVote":1,"tweetType":1,"viewCount":719,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":186592685,"gmtCreate":1623508242547,"gmtModify":1634032263677,"author":{"id":"3581987733859257","authorId":"3581987733859257","name":"huathuatkia","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581987733859257","idStr":"3581987733859257"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/186592685","repostId":"2142206100","repostType":4,"repost":{"id":"2142206100","kind":"highlight","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1623470400,"share":"https://www.laohu8.com/m/news/2142206100?lang=&edition=full","pubTime":"2021-06-12 12:00","market":"hk","language":"en","title":"15 momentum stocks expected to show the best sales growth over the next two years, including Carvana, Tesla and Palantir","url":"https://stock-news.laohu8.com/highlight/detail?id=2142206100","media":"Dow Jones","summary":"Several companies on a stock screen have estimated two-year revenue growth of over 100%.\nThere are m","content":"<p>Several companies on a stock screen have estimated two-year revenue growth of over 100%.</p>\n<p>There are many broad approaches to the stock market for selecting individual companies or groups for investments. Momentum investing -- trying to ride the wave of other investors' sentiment -- is popular for day-traders, especially during the current meme-stock craze. But it can also work over the long term.</p>\n<p>Below is a list of momentum stocks of companies expected to show the strongest sales growth over the next two years.</p>\n<p>Momentum ETF</p>\n<p>To begin with a large group of momentum stocks, we can look at the <a href=\"https://laohu8.com/S/MTUM\">iShares MSCI USA Momentum Factor</a> ETF (MTUM). This is the largest U.S. ETF that follows a momentum strategy, according to Mark Hulbert performance relative to its benchmark, the S&amp;P 500 Growth Index.</p>\n<p>For example, the largest holding of the ETF is Tesla Inc. <a href=\"https://laohu8.com/S/TSLA\">$(TSLA)$</a>, which \"has experienced strong risk-adjusted performance related to the market over the past 12 months,\" according to <a href=\"https://laohu8.com/S/EEME\">iShares</a> (a subsidiary of BlackRock Inc. <a href=\"https://laohu8.com/S/BLK\">$(BLK)$</a>). But shares of Merck &amp; Co. Inc. <a href=\"https://laohu8.com/S/MRK\">$(MRK)$</a> are excluded from MTUM because even though <a href=\"https://laohu8.com/S/EGRW\">iShares</a> considered its 12-month return \"attractive,\" the stock's six-month risk-adjusted return underperformed the benchmark.</p>\n<p>So keeping in mind the weighting by price performance relative to the index, tempered by volatility (going back as much as three years), here are the top 10 holdings of the <a href=\"https://laohu8.com/S/IHPXF\">iShares MSCI</a> USA Momentum Factor ETF:</p>\n<table>\n <tbody>\n  <tr>\n   <td>Company</td>\n   <td>Ticker</td>\n   <td>Share of MTUM</td>\n  </tr>\n  <tr>\n   <td>Tesla Inc.</td>\n   <td>TSLA</td>\n   <td>5.00%</td>\n  </tr>\n  <tr>\n   <td>JPMorgan Chase &amp; Co.</td>\n   <td>JPM</td>\n   <td>4.76%</td>\n  </tr>\n  <tr>\n   <td>Berkshire Hathaway Inc. Class B</td>\n   <td>BRK.B</td>\n   <td>4.58%</td>\n  </tr>\n  <tr>\n   <td>Walt Disney Co.</td>\n   <td>DIS</td>\n   <td>4.48%</td>\n  </tr>\n  <tr>\n   <td>$Bank of America Corp(BAC-N)$.</td>\n   <td>BAC</td>\n   <td>4.29%</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/PYPL\">PayPal</a> Holdings Inc.</td>\n   <td>PYPL</td>\n   <td>3.66%</td>\n  </tr>\n  <tr>\n   <td>Wells Fargo &amp; Co.</td>\n   <td>WFC</td>\n   <td>3.11%</td>\n  </tr>\n  <tr>\n   <td>Applied Materials Inc.</td>\n   <td>AMAT</td>\n   <td>3.00%</td>\n  </tr>\n  <tr>\n   <td>Alphabet Inc. Class C</td>\n   <td>GOOG</td>\n   <td>2.67%</td>\n  </tr>\n  <tr>\n   <td>Alphabet Inc. Class A</td>\n   <td>GOOGL</td>\n   <td>2.45%</td>\n  </tr>\n  <tr>\n   <td>Goldman Sachs Group Inc.</td>\n   <td>GS</td>\n   <td>2.30%</td>\n  </tr>\n  <tr>\n   <td>(FactSet)</td>\n   <td></td>\n   <td></td>\n  </tr>\n </tbody>\n</table>\n<p>Actually, there are 11 stocks listed, as MTUM holds both share classes of Alphabet Inc. Banks and insurers make up half the list, which makes sense because financials have been the second-best performing sector in the S&amp;P 500 , after the materials sector.</p>\n<p>Momentum stock screen -- expected sales growth</p>\n<p>Thinking again about financials, they have had plenty of momentum as investors have gained confidence the U.S. economy will continue roaring back from the damage caused by the coronavirus pandemic.</p>\n<p>But revenue growth can be an important driver, especially for individual stock prices over the long term. From here, the financials might not be the best place to look for rapidly rising revenue over the next two years.</p>\n<p>Starting with the 125 momentum stocks held by MTUM, here are the 15 companies expected by analysts polled by FactSet to increase revenue the most over the next two calendar years, with 2021 as the baseline. The figures are in millions of dollars:</p>\n<p>Those are stellar sales-growth numbers -- if the analysts are close to being correct. Many of the stocks are also expensive relative to the expected 2023 sales numbers. In comparison, the <a href=\"https://laohu8.com/S/EMDI\">iShares</a> S&amp;P 500 Growth ETF <a href=\"https://laohu8.com/S/IVW\">$(IVW)$</a> (which tracks the entire S&amp;P 500 Growth Index) trades for 4.2 times estimated 2023 sales.</p>\n<p>Plug Power Inc. <a href=\"https://laohu8.com/S/PLUG\">$(PLUG)$</a> tops the list, with analysts expecting sales to increase to $1.1 billion in 2023. The company said on June 10 it would build a hydrogen-production plant in Camden County, Ga.</p>\n<p><a href=\"https://laohu8.com/S/SNAP\">Snap Inc</a>. (SNAP) CEO Evan Spiegal said recently the company had grown to 500 million active daily users and that almost half of U.S. smartphone users were using Snapchat.</p>\n<p>Novavax Inc. <a href=\"https://laohu8.com/S/NVAX\">$(NVAX)$</a> expects to apply for FDA approval of its coronavirus vaccine during the third quarter.</p>\n<p><a href=\"https://laohu8.com/S/CVNA\">Carvana Co.</a> (CVNA) has been on a tear, with used-car demand spiking in the wake of component shortages for automobile production. The company's sales by units increased 76% in the first quarter from a year earlier.</p>\n<p>Uber Technologies Inc. <a href=\"https://laohu8.com/S/UBER\">$(UBER)$</a> and Lyft Inc <a href=\"https://laohu8.com/S/LYFT\">$(LYFT)$</a> are also expected to ride the economic recovery wave, although analysts expect Lyft to take longer to exceed its pre-pandemic revenue level .</p>\n<p><a href=\"https://laohu8.com/S/PLTR\">Palantir Technologies Inc.</a> (PLTR) rounds out the list. The developer of software used by government defense and intelligence agencies was included in this analysis of meme stocks .</p>\n<p>Earnings</p>\n<p>Some of these companies are still in relatively early growth stages, and aren't expected to achieve full-year profitability until 2023. Here are consensus earnings-per-share estimates for three years:</p>\n<p>Those are very high price-to-earnings ratios based on current stock prices and consensus estimates for 2023. But for rapidly growing companies, earnings typically aren't a priority, which explains why Amazon.com Inc. <a href=\"https://laohu8.com/S/AMZN\">$(AMZN)$</a> always trades at a high P/E. In comparison, the the <a href=\"https://laohu8.com/S/EMEY\">iShares</a> S&amp;P 500 Growth ETF trades for 23.3 times its weighted aggregate consensus earnings estimate for 2023.</p>\n<p>Wall Street's opinion</p>\n<p>Here's a summary of opinion about the 15 companies held by MTUM that analysts expect to grow their revenue the most over the next two years:</p>\n<p>The 12-month price targets may not be useful -- for traders, this is an eternity; it may be a short period for long-term investors looking to profit for years as sales (and hopefully earnings, eventually) compound. It is important to do your own research and form your own opinion about a company's financial health and its ability to remain competitive.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>15 momentum stocks expected to show the best sales growth over the next two years, including Carvana, Tesla and Palantir</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n15 momentum stocks expected to show the best sales growth over the next two years, including Carvana, Tesla and Palantir\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-06-12 12:00</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Several companies on a stock screen have estimated two-year revenue growth of over 100%.</p>\n<p>There are many broad approaches to the stock market for selecting individual companies or groups for investments. Momentum investing -- trying to ride the wave of other investors' sentiment -- is popular for day-traders, especially during the current meme-stock craze. But it can also work over the long term.</p>\n<p>Below is a list of momentum stocks of companies expected to show the strongest sales growth over the next two years.</p>\n<p>Momentum ETF</p>\n<p>To begin with a large group of momentum stocks, we can look at the <a href=\"https://laohu8.com/S/MTUM\">iShares MSCI USA Momentum Factor</a> ETF (MTUM). This is the largest U.S. ETF that follows a momentum strategy, according to Mark Hulbert performance relative to its benchmark, the S&amp;P 500 Growth Index.</p>\n<p>For example, the largest holding of the ETF is Tesla Inc. <a href=\"https://laohu8.com/S/TSLA\">$(TSLA)$</a>, which \"has experienced strong risk-adjusted performance related to the market over the past 12 months,\" according to <a href=\"https://laohu8.com/S/EEME\">iShares</a> (a subsidiary of BlackRock Inc. <a href=\"https://laohu8.com/S/BLK\">$(BLK)$</a>). But shares of Merck &amp; Co. Inc. <a href=\"https://laohu8.com/S/MRK\">$(MRK)$</a> are excluded from MTUM because even though <a href=\"https://laohu8.com/S/EGRW\">iShares</a> considered its 12-month return \"attractive,\" the stock's six-month risk-adjusted return underperformed the benchmark.</p>\n<p>So keeping in mind the weighting by price performance relative to the index, tempered by volatility (going back as much as three years), here are the top 10 holdings of the <a href=\"https://laohu8.com/S/IHPXF\">iShares MSCI</a> USA Momentum Factor ETF:</p>\n<table>\n <tbody>\n  <tr>\n   <td>Company</td>\n   <td>Ticker</td>\n   <td>Share of MTUM</td>\n  </tr>\n  <tr>\n   <td>Tesla Inc.</td>\n   <td>TSLA</td>\n   <td>5.00%</td>\n  </tr>\n  <tr>\n   <td>JPMorgan Chase &amp; Co.</td>\n   <td>JPM</td>\n   <td>4.76%</td>\n  </tr>\n  <tr>\n   <td>Berkshire Hathaway Inc. Class B</td>\n   <td>BRK.B</td>\n   <td>4.58%</td>\n  </tr>\n  <tr>\n   <td>Walt Disney Co.</td>\n   <td>DIS</td>\n   <td>4.48%</td>\n  </tr>\n  <tr>\n   <td>$Bank of America Corp(BAC-N)$.</td>\n   <td>BAC</td>\n   <td>4.29%</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/PYPL\">PayPal</a> Holdings Inc.</td>\n   <td>PYPL</td>\n   <td>3.66%</td>\n  </tr>\n  <tr>\n   <td>Wells Fargo &amp; Co.</td>\n   <td>WFC</td>\n   <td>3.11%</td>\n  </tr>\n  <tr>\n   <td>Applied Materials Inc.</td>\n   <td>AMAT</td>\n   <td>3.00%</td>\n  </tr>\n  <tr>\n   <td>Alphabet Inc. Class C</td>\n   <td>GOOG</td>\n   <td>2.67%</td>\n  </tr>\n  <tr>\n   <td>Alphabet Inc. Class A</td>\n   <td>GOOGL</td>\n   <td>2.45%</td>\n  </tr>\n  <tr>\n   <td>Goldman Sachs Group Inc.</td>\n   <td>GS</td>\n   <td>2.30%</td>\n  </tr>\n  <tr>\n   <td>(FactSet)</td>\n   <td></td>\n   <td></td>\n  </tr>\n </tbody>\n</table>\n<p>Actually, there are 11 stocks listed, as MTUM holds both share classes of Alphabet Inc. Banks and insurers make up half the list, which makes sense because financials have been the second-best performing sector in the S&amp;P 500 , after the materials sector.</p>\n<p>Momentum stock screen -- expected sales growth</p>\n<p>Thinking again about financials, they have had plenty of momentum as investors have gained confidence the U.S. economy will continue roaring back from the damage caused by the coronavirus pandemic.</p>\n<p>But revenue growth can be an important driver, especially for individual stock prices over the long term. From here, the financials might not be the best place to look for rapidly rising revenue over the next two years.</p>\n<p>Starting with the 125 momentum stocks held by MTUM, here are the 15 companies expected by analysts polled by FactSet to increase revenue the most over the next two calendar years, with 2021 as the baseline. The figures are in millions of dollars:</p>\n<p>Those are stellar sales-growth numbers -- if the analysts are close to being correct. Many of the stocks are also expensive relative to the expected 2023 sales numbers. In comparison, the <a href=\"https://laohu8.com/S/EMDI\">iShares</a> S&amp;P 500 Growth ETF <a href=\"https://laohu8.com/S/IVW\">$(IVW)$</a> (which tracks the entire S&amp;P 500 Growth Index) trades for 4.2 times estimated 2023 sales.</p>\n<p>Plug Power Inc. <a href=\"https://laohu8.com/S/PLUG\">$(PLUG)$</a> tops the list, with analysts expecting sales to increase to $1.1 billion in 2023. The company said on June 10 it would build a hydrogen-production plant in Camden County, Ga.</p>\n<p><a href=\"https://laohu8.com/S/SNAP\">Snap Inc</a>. (SNAP) CEO Evan Spiegal said recently the company had grown to 500 million active daily users and that almost half of U.S. smartphone users were using Snapchat.</p>\n<p>Novavax Inc. <a href=\"https://laohu8.com/S/NVAX\">$(NVAX)$</a> expects to apply for FDA approval of its coronavirus vaccine during the third quarter.</p>\n<p><a href=\"https://laohu8.com/S/CVNA\">Carvana Co.</a> (CVNA) has been on a tear, with used-car demand spiking in the wake of component shortages for automobile production. The company's sales by units increased 76% in the first quarter from a year earlier.</p>\n<p>Uber Technologies Inc. <a href=\"https://laohu8.com/S/UBER\">$(UBER)$</a> and Lyft Inc <a href=\"https://laohu8.com/S/LYFT\">$(LYFT)$</a> are also expected to ride the economic recovery wave, although analysts expect Lyft to take longer to exceed its pre-pandemic revenue level .</p>\n<p><a href=\"https://laohu8.com/S/PLTR\">Palantir Technologies Inc.</a> (PLTR) rounds out the list. The developer of software used by government defense and intelligence agencies was included in this analysis of meme stocks .</p>\n<p>Earnings</p>\n<p>Some of these companies are still in relatively early growth stages, and aren't expected to achieve full-year profitability until 2023. Here are consensus earnings-per-share estimates for three years:</p>\n<p>Those are very high price-to-earnings ratios based on current stock prices and consensus estimates for 2023. But for rapidly growing companies, earnings typically aren't a priority, which explains why Amazon.com Inc. <a href=\"https://laohu8.com/S/AMZN\">$(AMZN)$</a> always trades at a high P/E. In comparison, the the <a href=\"https://laohu8.com/S/EMEY\">iShares</a> S&amp;P 500 Growth ETF trades for 23.3 times its weighted aggregate consensus earnings estimate for 2023.</p>\n<p>Wall Street's opinion</p>\n<p>Here's a summary of opinion about the 15 companies held by MTUM that analysts expect to grow their revenue the most over the next two years:</p>\n<p>The 12-month price targets may not be useful -- for traders, this is an eternity; it may be a short period for long-term investors looking to profit for years as sales (and hopefully earnings, eventually) compound. It is important to do your own research and form your own opinion about a company's financial health and its ability to remain competitive.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PLTR":"Palantir Technologies Inc.","SNAP":"Snap Inc","CVNA":"Carvana Co.","TSLA":"特斯拉","PLUG":"普拉格能源"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2142206100","content_text":"Several companies on a stock screen have estimated two-year revenue growth of over 100%.\nThere are many broad approaches to the stock market for selecting individual companies or groups for investments. Momentum investing -- trying to ride the wave of other investors' sentiment -- is popular for day-traders, especially during the current meme-stock craze. But it can also work over the long term.\nBelow is a list of momentum stocks of companies expected to show the strongest sales growth over the next two years.\nMomentum ETF\nTo begin with a large group of momentum stocks, we can look at the iShares MSCI USA Momentum Factor ETF (MTUM). This is the largest U.S. ETF that follows a momentum strategy, according to Mark Hulbert performance relative to its benchmark, the S&P 500 Growth Index.\nFor example, the largest holding of the ETF is Tesla Inc. $(TSLA)$, which \"has experienced strong risk-adjusted performance related to the market over the past 12 months,\" according to iShares (a subsidiary of BlackRock Inc. $(BLK)$). But shares of Merck & Co. Inc. $(MRK)$ are excluded from MTUM because even though iShares considered its 12-month return \"attractive,\" the stock's six-month risk-adjusted return underperformed the benchmark.\nSo keeping in mind the weighting by price performance relative to the index, tempered by volatility (going back as much as three years), here are the top 10 holdings of the iShares MSCI USA Momentum Factor ETF:\n\n\n\nCompany\nTicker\nShare of MTUM\n\n\nTesla Inc.\nTSLA\n5.00%\n\n\nJPMorgan Chase & Co.\nJPM\n4.76%\n\n\nBerkshire Hathaway Inc. Class B\nBRK.B\n4.58%\n\n\nWalt Disney Co.\nDIS\n4.48%\n\n\n$Bank of America Corp(BAC-N)$.\nBAC\n4.29%\n\n\nPayPal Holdings Inc.\nPYPL\n3.66%\n\n\nWells Fargo & Co.\nWFC\n3.11%\n\n\nApplied Materials Inc.\nAMAT\n3.00%\n\n\nAlphabet Inc. Class C\nGOOG\n2.67%\n\n\nAlphabet Inc. Class A\nGOOGL\n2.45%\n\n\nGoldman Sachs Group Inc.\nGS\n2.30%\n\n\n(FactSet)\n\n\n\n\n\nActually, there are 11 stocks listed, as MTUM holds both share classes of Alphabet Inc. Banks and insurers make up half the list, which makes sense because financials have been the second-best performing sector in the S&P 500 , after the materials sector.\nMomentum stock screen -- expected sales growth\nThinking again about financials, they have had plenty of momentum as investors have gained confidence the U.S. economy will continue roaring back from the damage caused by the coronavirus pandemic.\nBut revenue growth can be an important driver, especially for individual stock prices over the long term. From here, the financials might not be the best place to look for rapidly rising revenue over the next two years.\nStarting with the 125 momentum stocks held by MTUM, here are the 15 companies expected by analysts polled by FactSet to increase revenue the most over the next two calendar years, with 2021 as the baseline. The figures are in millions of dollars:\nThose are stellar sales-growth numbers -- if the analysts are close to being correct. Many of the stocks are also expensive relative to the expected 2023 sales numbers. In comparison, the iShares S&P 500 Growth ETF $(IVW)$ (which tracks the entire S&P 500 Growth Index) trades for 4.2 times estimated 2023 sales.\nPlug Power Inc. $(PLUG)$ tops the list, with analysts expecting sales to increase to $1.1 billion in 2023. The company said on June 10 it would build a hydrogen-production plant in Camden County, Ga.\nSnap Inc. (SNAP) CEO Evan Spiegal said recently the company had grown to 500 million active daily users and that almost half of U.S. smartphone users were using Snapchat.\nNovavax Inc. $(NVAX)$ expects to apply for FDA approval of its coronavirus vaccine during the third quarter.\nCarvana Co. (CVNA) has been on a tear, with used-car demand spiking in the wake of component shortages for automobile production. The company's sales by units increased 76% in the first quarter from a year earlier.\nUber Technologies Inc. $(UBER)$ and Lyft Inc $(LYFT)$ are also expected to ride the economic recovery wave, although analysts expect Lyft to take longer to exceed its pre-pandemic revenue level .\nPalantir Technologies Inc. (PLTR) rounds out the list. The developer of software used by government defense and intelligence agencies was included in this analysis of meme stocks .\nEarnings\nSome of these companies are still in relatively early growth stages, and aren't expected to achieve full-year profitability until 2023. Here are consensus earnings-per-share estimates for three years:\nThose are very high price-to-earnings ratios based on current stock prices and consensus estimates for 2023. But for rapidly growing companies, earnings typically aren't a priority, which explains why Amazon.com Inc. $(AMZN)$ always trades at a high P/E. In comparison, the the iShares S&P 500 Growth ETF trades for 23.3 times its weighted aggregate consensus earnings estimate for 2023.\nWall Street's opinion\nHere's a summary of opinion about the 15 companies held by MTUM that analysts expect to grow their revenue the most over the next two years:\nThe 12-month price targets may not be useful -- for traders, this is an eternity; it may be a short period for long-term investors looking to profit for years as sales (and hopefully earnings, eventually) compound. It is important to do your own research and form your own opinion about a company's financial health and its ability to remain competitive.","news_type":1},"isVote":1,"tweetType":1,"viewCount":406,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":186531655,"gmtCreate":1623508933577,"gmtModify":1634032257901,"author":{"id":"3581987733859257","authorId":"3581987733859257","name":"huathuatkia","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581987733859257","authorIdStr":"3581987733859257"},"themes":[],"htmlText":"Kk","listText":"Kk","text":"Kk","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/186531655","repostId":"2142270837","repostType":4,"repost":{"id":"2142270837","kind":"highlight","pubTimestamp":1623424800,"share":"https://www.laohu8.com/m/news/2142270837?lang=&edition=full","pubTime":"2021-06-11 23:20","market":"us","language":"en","title":"Move Over, AMC and Dogecoin -- This Stock Could Be a Much Bigger Long-Term Winner","url":"https://stock-news.laohu8.com/highlight/detail?id=2142270837","media":"Motley Fool","summary":"It has a key advantage that should make a huge difference over the next 10 or more years.","content":"<p>You won't find hotter stars in the investing universe so far this year than&nbsp;<b>AMC Entertainment</b> (NYSE:AMC) and <b>Dogecoin</b> (CRYPTO:DOGE). Retail investors have jumped aboard their bandwagons in force. AMC's shares have vaulted more than 2,300% higher year to date, while the price of Dogecoin has skyrocketed over 5,600%.</p>\n<p>The big question for AMC and Dogecoin is whether or not their momentum is sustainable. There's considerable disagreement about the right answer to that question.</p>\n<p>Probably the better question to ask, though, is whether or not there are other investment alternatives that provide better risk-reward propositions over the next 10 years or more. My view is that the answer to this question is a resounding \"yes.\"</p>\n<p>Move over AMC and Dogecoin: Here's a stock that could be a bigger long-term winner.</p>\n<p><img src=\"https://static.tigerbbs.com/60aa704652c60d9c305da0999c714b57\" tg-width=\"700\" tg-height=\"525\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: Getty Images.</p>\n<h2>A big advantage for a big biotech</h2>\n<p>The stock I have in mind is none other than&nbsp;<b>Vertex Pharmaceuticals</b> (NASDAQ:VRTX). Granted, Vertex hasn't delivered anywhere close to the kinds of returns that AMC and Dogecoin have in recent months. It even just reported a setback for <a href=\"https://laohu8.com/S/AONE\">one</a> of its pipeline candidates. However, this big biotech holds an advantage over both of them that should make a huge difference over the long run: Vertex enjoys a monopoly in its core market.</p>\n<p>There are currently four approved drugs in the U.S. and Europe that treat the underlying cause of rare genetic disease cystic fibrosis (CF), and Vertex markets all of them. Its newest CF drug, Trikafta/Kaftrio, is its biggest winner yet. The drug is just beginning to pick up momentum in Europe.</p>\n<p>What about potential rivals? <a href=\"https://laohu8.com/S/TWOA.U\">Two</a> other companies have clinical-stage candidates that target the underlying cause of CF. However, those experimental drugs are only in phase 2 testing, and there's no guarantee the candidates will be more effective than Vertex's products that are already on the market. Vertex seems likely to dominate the CF market, at least through the next decade.</p>\n<p>Let's compare Vertex's monopoly to the competitive dynamics for AMC and Dogecoin. AMC isn't the only theater chain. Its top rivals include <b>Cineplex</b>, <b>Cinemark</b>, <b>Marcus</b>, and Regal Entertainment. Streaming services that allow people to watch new movies at home are also a competitive threat to AMC.</p>\n<p>Dogecoin isn't the only cryptocurrency vying for investors' favor, either. There are other cryptocurrencies that seem even more likely to succeed over the next several years than Dogecoin.</p>\n<p>The bottom line is that Vertex has a moat, while AMC and Dogecoin don't. Over the long run, moats matter.</p>\n<h2>Looking to the future</h2>\n<p>Dogecoin likely has a hit-or-miss future. It either will become a top cryptocurrency that enjoys enduring use or it will fade away.</p>\n<p>On the other hand, AMC will probably experience a solid rebound as life returns to normal with fears about the COVID-19 pandemic waning. That should boost the company's sales this year and into 2022. But how long can AMC's growth story last? Movie-theater attendance was declining somewhat even before the pandemic. It won't be surprising to see that trend resume after an initial resurgence.</p>\n<p>Meanwhile, Vertex continues to focus on treating the remaining 10% of CF patients that its current drugs can't help. The company is also developing experimental therapies for other rare diseases, including alpha-1 antitrypsin deficiency, APOL1-mediated kidney diseases, beta-thalassemia, Duchenne muscular dystrophy, and sickle cell disease.</p>\n<p>Vertex isn't limiting itself to just rare diseases, though. It's testing an experimental drug for the treatment of acute pain following certain types of surgeries in phase 2 clinical trials. The biotech is evaluating a gene therapy in a phase 1/2 study that holds the potential to essentially cure type 1 diabetes</p>\n<p>The important thing to note is that Vertex doesn't need all of these programs to be successful. If only <a href=\"https://laohu8.com/S/AONE.U\">one</a> or two of them pan out, this biotech stock should deliver tremendous returns.</p>\n<h2>Beyond the hype</h2>\n<p>I think it's quite possible that AMC and/or Dogecoin will outperform Vertex over the short term. If you're a short-term trader looking to capture quick profits, that's great. However, my focus from the beginning has been on the long term.</p>\n<p>Sooner or later, the hype for AMC and Dogecoin will die down. What happens then? Short-term traders will turn to another stock or cryptocurrency to ride.</p>\n<p>Vertex, though, is working every single day to treat and even cure diseases that cause suffering for many people around the world. Its CF franchise is generating billions of dollars in sales every year, and the company is using its growing cash stockpile to fund further development and make more deals to bolster its pipeline.</p>\n<p>My view is that these continuous efforts will make Vertex a bigger winner than either AMC or Dogecoin over the long term.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Move Over, AMC and Dogecoin -- This Stock Could Be a Much Bigger Long-Term Winner</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMove Over, AMC and Dogecoin -- This Stock Could Be a Much Bigger Long-Term Winner\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-11 23:20 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/11/move-over-amc-and-dogecoin-this-stock-could-be-a-m/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>You won't find hotter stars in the investing universe so far this year than AMC Entertainment (NYSE:AMC) and Dogecoin (CRYPTO:DOGE). Retail investors have jumped aboard their bandwagons in force. AMC'...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/11/move-over-amc-and-dogecoin-this-stock-could-be-a-m/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VERX":"Vertex, Inc."},"source_url":"https://www.fool.com/investing/2021/06/11/move-over-amc-and-dogecoin-this-stock-could-be-a-m/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2142270837","content_text":"You won't find hotter stars in the investing universe so far this year than AMC Entertainment (NYSE:AMC) and Dogecoin (CRYPTO:DOGE). Retail investors have jumped aboard their bandwagons in force. AMC's shares have vaulted more than 2,300% higher year to date, while the price of Dogecoin has skyrocketed over 5,600%.\nThe big question for AMC and Dogecoin is whether or not their momentum is sustainable. There's considerable disagreement about the right answer to that question.\nProbably the better question to ask, though, is whether or not there are other investment alternatives that provide better risk-reward propositions over the next 10 years or more. My view is that the answer to this question is a resounding \"yes.\"\nMove over AMC and Dogecoin: Here's a stock that could be a bigger long-term winner.\n\nImage source: Getty Images.\nA big advantage for a big biotech\nThe stock I have in mind is none other than Vertex Pharmaceuticals (NASDAQ:VRTX). Granted, Vertex hasn't delivered anywhere close to the kinds of returns that AMC and Dogecoin have in recent months. It even just reported a setback for one of its pipeline candidates. However, this big biotech holds an advantage over both of them that should make a huge difference over the long run: Vertex enjoys a monopoly in its core market.\nThere are currently four approved drugs in the U.S. and Europe that treat the underlying cause of rare genetic disease cystic fibrosis (CF), and Vertex markets all of them. Its newest CF drug, Trikafta/Kaftrio, is its biggest winner yet. The drug is just beginning to pick up momentum in Europe.\nWhat about potential rivals? Two other companies have clinical-stage candidates that target the underlying cause of CF. However, those experimental drugs are only in phase 2 testing, and there's no guarantee the candidates will be more effective than Vertex's products that are already on the market. Vertex seems likely to dominate the CF market, at least through the next decade.\nLet's compare Vertex's monopoly to the competitive dynamics for AMC and Dogecoin. AMC isn't the only theater chain. Its top rivals include Cineplex, Cinemark, Marcus, and Regal Entertainment. Streaming services that allow people to watch new movies at home are also a competitive threat to AMC.\nDogecoin isn't the only cryptocurrency vying for investors' favor, either. There are other cryptocurrencies that seem even more likely to succeed over the next several years than Dogecoin.\nThe bottom line is that Vertex has a moat, while AMC and Dogecoin don't. Over the long run, moats matter.\nLooking to the future\nDogecoin likely has a hit-or-miss future. It either will become a top cryptocurrency that enjoys enduring use or it will fade away.\nOn the other hand, AMC will probably experience a solid rebound as life returns to normal with fears about the COVID-19 pandemic waning. That should boost the company's sales this year and into 2022. But how long can AMC's growth story last? Movie-theater attendance was declining somewhat even before the pandemic. It won't be surprising to see that trend resume after an initial resurgence.\nMeanwhile, Vertex continues to focus on treating the remaining 10% of CF patients that its current drugs can't help. The company is also developing experimental therapies for other rare diseases, including alpha-1 antitrypsin deficiency, APOL1-mediated kidney diseases, beta-thalassemia, Duchenne muscular dystrophy, and sickle cell disease.\nVertex isn't limiting itself to just rare diseases, though. It's testing an experimental drug for the treatment of acute pain following certain types of surgeries in phase 2 clinical trials. The biotech is evaluating a gene therapy in a phase 1/2 study that holds the potential to essentially cure type 1 diabetes\nThe important thing to note is that Vertex doesn't need all of these programs to be successful. If only one or two of them pan out, this biotech stock should deliver tremendous returns.\nBeyond the hype\nI think it's quite possible that AMC and/or Dogecoin will outperform Vertex over the short term. If you're a short-term trader looking to capture quick profits, that's great. However, my focus from the beginning has been on the long term.\nSooner or later, the hype for AMC and Dogecoin will die down. What happens then? Short-term traders will turn to another stock or cryptocurrency to ride.\nVertex, though, is working every single day to treat and even cure diseases that cause suffering for many people around the world. Its CF franchise is generating billions of dollars in sales every year, and the company is using its growing cash stockpile to fund further development and make more deals to bolster its pipeline.\nMy view is that these continuous efforts will make Vertex a bigger winner than either AMC or Dogecoin over the long term.","news_type":1},"isVote":1,"tweetType":1,"viewCount":388,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":186594506,"gmtCreate":1623508389905,"gmtModify":1634032261881,"author":{"id":"3581987733859257","authorId":"3581987733859257","name":"huathuatkia","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581987733859257","authorIdStr":"3581987733859257"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/186594506","repostId":"1124998394","repostType":4,"repost":{"id":"1124998394","kind":"news","pubTimestamp":1623468911,"share":"https://www.laohu8.com/m/news/1124998394?lang=&edition=full","pubTime":"2021-06-12 11:35","market":"us","language":"en","title":"Markets await the Fed’s meeting before making the next big move in the week ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=1124998394","media":"cnbc","summary":"KEY POINTS\n\nThe Federal Reserve’s June meeting is the big event for markets in the week ahead, thoug","content":"<div>\n<p>KEY POINTS\n\nThe Federal Reserve’s June meeting is the big event for markets in the week ahead, though it is not expected to take any action.\nStocks meandered Friday, and traders see the potential for ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/11/markets-await-the-feds-meeting-in-the-week-ahead.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Markets await the Fed’s meeting before making the next big move in the week ahead</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMarkets await the Fed’s meeting before making the next big move in the week ahead\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-12 11:35 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/06/11/markets-await-the-feds-meeting-in-the-week-ahead.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTS\n\nThe Federal Reserve’s June meeting is the big event for markets in the week ahead, though it is not expected to take any action.\nStocks meandered Friday, and traders see the potential for ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/11/markets-await-the-feds-meeting-in-the-week-ahead.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯",".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite","SPY":"标普500ETF"},"source_url":"https://www.cnbc.com/2021/06/11/markets-await-the-feds-meeting-in-the-week-ahead.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1124998394","content_text":"KEY POINTS\n\nThe Federal Reserve’s June meeting is the big event for markets in the week ahead, though it is not expected to take any action.\nStocks meandered Friday, and traders see the potential for a sideways move early next week as investors await the outcome of the central bank’s meeting Wednesday afternoon.\nMarket pros are watching to see if the Fed tweaks its forecasts for interest rates or inflation.\n\nStocks could trade sideways as investors await the outcome of the Federal Reserve’s June meeting next Wednesday afternoon.\nThe Fed’s two-day meeting is the big event for markets in the week ahead. Although the central bank is not expected to take any action, it could make tweaks to its forecasts for interest rates and inflation that market pros say could be market moving.\nStocks meandered Friday and theS&P 500finished at a new high, garnering a 0.4% gain for the week.\n“Markets have to get past Wednesday before anyone makes huge bets,” said Scott Redler, chief strategic officer at T3Live.com. “It’s really that the Street’s looking at the next big obstacle — which is the Fed.”\nThe market is attuned to any discussion about the central bank’s bond-buying program. The program was initiated during the pandemic to provide liquidity to the markets and keep interest rates low. TheFed is widely expected to acknowledgeit will start tapering back on that so-called quantitative easing program later this year.\nOnce the central bank signals it will cut back on its $120 billion monthly bond purchases, it is basically signaling a major shift in its policy from easing to tightening. The Fed is expected to signal a taper well before it takes any action, and its own forecast for interest rates does not show any increases through 2023.\nFed Chairman Jerome Powell briefs journalists after the central bank issues its statement at 2 p.m. ET on Wednesday. He is expected to sound dovish and assure markets the Fed’s policy will remain easy .\n“Let’s say for some reason Powell intimates tapering could happen late this year, not just talk about it but do it,” said Mike Schumacher, head of rate strategy at Wells Fargo. “That would spook the market, or if we get a big increase in inflation projections that would get the markets a little spooked.”\nEconomic calendar\nThere are a few economic reports worth watching, particularlyTuesday’s retail sales for Mayand theproducer price index— a look at producer level inflation.\nThe Federal Reserve will also release itsindustrial production index data, which measures production and capacity in manufacturing, mining and other industries, on Tuesday.\n“Essentially, I think nominal retail sales might be strong,” said Aneta Markowska, chief financial economist at Jefferies. “I just think the only thing that thing the market cares about right now is employment because that’s the only thing that can move the needle on the Fed.”\nThemarkets this past week shrugged off a super hot consumer inflation readingfor May, reported Thursday. Economists said the 5% jump in the consumer price index appears to be a temporary reaction to the reopening economy, supply chain disruptions and pent-up demand. But they also said it will take a few more reports to make sure it is not more persistent than the Fed currently expects.\nThe central bank has said it expects inflation to be high for a short period before falling back down, closer to 2%. The Fed will likely raise its forecast of2.2% for this year, given the jump in recent inflation readings.\nIt also predicts that core inflation, as measured by thepersonal consumption expenditures price index, will be at 2% in 2022 and 2.1% in 2023.\nWells Fargo’s Schumacher said he is closely watching that inflation forecast, particularly for 2023. According to the Fed’s interest rate forecast, that is also the first time a group of central bank officials see the potential for an increase in the fed funds target rate.\nSo if inflation is higher in their view, the outlook for interest rates could be as well. That could move forward the forecast for the first rate hike, now forecast by a majority of the Fed in 2024.\n“If that number goes up a tenth, that’s a non-event. If it goes up 0.3, it’s a lot in terms of the way the Fed looks at the world,” Schumacher said. The Fed has said it would tolerate inflation above its 2% target for a period of time before it acts.\nMarkowska of Jefferies doubts the Fed rate forecast will shift. The forecast is presented in a so-called “dot plot” with anonymous entries from central bank officials.\nShe noted in March, Federal Open Market Committee participants weresplit 11 to 7 against a 2023 hike, which means three officials would have to change their mind in order to move the median forecast.\n“My base case is it won’t move,” she said. “I just feel like there hasn’t been enough definitive change in the data to really change the Fed’s forecast. Having said that, you just need three people to change their mind. Even if that median forecast goes up, Powell is just going to downplay it during the press conference.”\nShe pointed to thedisappointing May employment report, which showed 559,000 jobs were added, 100,000 less than expected.\nWatch bonds\nStocks finished the past week mixed, with theDowdown 0.8% at 34,479, and theS&P 500eking out a gain of 0.4% to finish the week at a record 4,247. TheNasdaq,boosted by tech, gained nearly 1.9% to reach 14,069. Meanwhile the small-capRussell 2000outperformed the other indices, increasing by 2.2% for the week and landing at 2,335.\nREITs were the best performing major sector for the week, up 2%, followed by the health care sector’s 1.9% gain. Consumer discretionary stocks rose 1.6%. Tech climbed 1.4%, helped by a decline in interest rates.\nBut the financial sector lost 2.4% as interest rates fell, and it was the worst performing sector this week. Financials fell with other cyclicals, like materials, off 2% for the week and industrials off 1.7%.\nMeme stocks remained in the headlinesand continued to trade with a high level of volatility.GameStophit a high of $344.66 Tuesday and dropped as low as $206.13 Friday before closing at $233.34 per share.\nBesides the wild ride by meme stocks in the past week, the market to watch was Treasurys, as yields took a surprising slide. There was a fairly dramatic move in the rate of the benchmark10-year,watched most closely by investors, as it influences mortgages and other important lending rates.\nThe 10-year Treasury yield dipped under 1.43% on Friday. Yields move opposite price, so the move downward represented a buying surge.\n“I feel like this entire move in Treasurys is technical and has nothing to do with fundamentals,” said Jefferies’ Markowska. She said institutions are finding super low yields in Treasury bills and the overnight rates markets. “There’s just an excess of cash that is spilling out to the longer maturities,” she said. “People are still very short.”\nMarkowska said the weaker than expected May jobs report spurred buying that forced some short investors, who bet on higher yields, to cover those positions as rates fell.\nThe fall in the 10-year yield, which hit a high of 1.75% in late March, has been a positive for stocks. It also hasdrawn some stock investors to tech and growth sectors,which had fallen out of favor.\n“Most people in the market will tell you yields will rise significantly at some point. The question is when,” said Schumacher. Many forecasters expect the 10-year yield to reach 2% by the end of the year.\nFinally, investors will also be watching headlines from President Joe Biden’s trip to the U.K. and Europe, where he is attending the G-7 and a meeting with NATO allies. He willhold a summitwith Russian President Vladimir Putin on Wednesday in Geneva.\nWeek ahead calendar\nTuesday\nThe Federal Open Market Committee begins two-day meeting\nEarnings:Oracle,La-Z-Boy, H&R Block\n8:30 a.m. Retail sales\n8:30 a.m. PPI\n9:15 a.m. Empire State manufacturing\n10:00 a.m. Industrial production\n10:00 a.m. Business inventories\n10:00 a.m. NAHB survey\n4:00 p.m. TIC data\nWednesday\nEarnings:Lennar,The Honest Company\n8:30 a.m. Housing starts\n8:30 a.m. Import prices\n8:30 a.m. Business leaders survey\n2:00 p.m. FOMC statement\n2:30 p.m. Fed Chairman Jerome Powell briefing\nThursday\nEarnings:Adobe,Kroger,Jabil,Commercial Metals, Smith and Wesson\n8:30 a.m. Initial jobless claims\n8:30 a.m. Philadelphia Fed manufacturing","news_type":1},"isVote":1,"tweetType":1,"viewCount":719,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":186592685,"gmtCreate":1623508242547,"gmtModify":1634032263677,"author":{"id":"3581987733859257","authorId":"3581987733859257","name":"huathuatkia","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581987733859257","authorIdStr":"3581987733859257"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/186592685","repostId":"2142206100","repostType":4,"repost":{"id":"2142206100","kind":"highlight","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1623470400,"share":"https://www.laohu8.com/m/news/2142206100?lang=&edition=full","pubTime":"2021-06-12 12:00","market":"hk","language":"en","title":"15 momentum stocks expected to show the best sales growth over the next two years, including Carvana, Tesla and Palantir","url":"https://stock-news.laohu8.com/highlight/detail?id=2142206100","media":"Dow Jones","summary":"Several companies on a stock screen have estimated two-year revenue growth of over 100%.\nThere are m","content":"<p>Several companies on a stock screen have estimated two-year revenue growth of over 100%.</p>\n<p>There are many broad approaches to the stock market for selecting individual companies or groups for investments. Momentum investing -- trying to ride the wave of other investors' sentiment -- is popular for day-traders, especially during the current meme-stock craze. But it can also work over the long term.</p>\n<p>Below is a list of momentum stocks of companies expected to show the strongest sales growth over the next two years.</p>\n<p>Momentum ETF</p>\n<p>To begin with a large group of momentum stocks, we can look at the <a href=\"https://laohu8.com/S/MTUM\">iShares MSCI USA Momentum Factor</a> ETF (MTUM). This is the largest U.S. ETF that follows a momentum strategy, according to Mark Hulbert performance relative to its benchmark, the S&amp;P 500 Growth Index.</p>\n<p>For example, the largest holding of the ETF is Tesla Inc. <a href=\"https://laohu8.com/S/TSLA\">$(TSLA)$</a>, which \"has experienced strong risk-adjusted performance related to the market over the past 12 months,\" according to <a href=\"https://laohu8.com/S/EEME\">iShares</a> (a subsidiary of BlackRock Inc. <a href=\"https://laohu8.com/S/BLK\">$(BLK)$</a>). But shares of Merck &amp; Co. Inc. <a href=\"https://laohu8.com/S/MRK\">$(MRK)$</a> are excluded from MTUM because even though <a href=\"https://laohu8.com/S/EGRW\">iShares</a> considered its 12-month return \"attractive,\" the stock's six-month risk-adjusted return underperformed the benchmark.</p>\n<p>So keeping in mind the weighting by price performance relative to the index, tempered by volatility (going back as much as three years), here are the top 10 holdings of the <a href=\"https://laohu8.com/S/IHPXF\">iShares MSCI</a> USA Momentum Factor ETF:</p>\n<table>\n <tbody>\n  <tr>\n   <td>Company</td>\n   <td>Ticker</td>\n   <td>Share of MTUM</td>\n  </tr>\n  <tr>\n   <td>Tesla Inc.</td>\n   <td>TSLA</td>\n   <td>5.00%</td>\n  </tr>\n  <tr>\n   <td>JPMorgan Chase &amp; Co.</td>\n   <td>JPM</td>\n   <td>4.76%</td>\n  </tr>\n  <tr>\n   <td>Berkshire Hathaway Inc. Class B</td>\n   <td>BRK.B</td>\n   <td>4.58%</td>\n  </tr>\n  <tr>\n   <td>Walt Disney Co.</td>\n   <td>DIS</td>\n   <td>4.48%</td>\n  </tr>\n  <tr>\n   <td>$Bank of America Corp(BAC-N)$.</td>\n   <td>BAC</td>\n   <td>4.29%</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/PYPL\">PayPal</a> Holdings Inc.</td>\n   <td>PYPL</td>\n   <td>3.66%</td>\n  </tr>\n  <tr>\n   <td>Wells Fargo &amp; Co.</td>\n   <td>WFC</td>\n   <td>3.11%</td>\n  </tr>\n  <tr>\n   <td>Applied Materials Inc.</td>\n   <td>AMAT</td>\n   <td>3.00%</td>\n  </tr>\n  <tr>\n   <td>Alphabet Inc. Class C</td>\n   <td>GOOG</td>\n   <td>2.67%</td>\n  </tr>\n  <tr>\n   <td>Alphabet Inc. Class A</td>\n   <td>GOOGL</td>\n   <td>2.45%</td>\n  </tr>\n  <tr>\n   <td>Goldman Sachs Group Inc.</td>\n   <td>GS</td>\n   <td>2.30%</td>\n  </tr>\n  <tr>\n   <td>(FactSet)</td>\n   <td></td>\n   <td></td>\n  </tr>\n </tbody>\n</table>\n<p>Actually, there are 11 stocks listed, as MTUM holds both share classes of Alphabet Inc. Banks and insurers make up half the list, which makes sense because financials have been the second-best performing sector in the S&amp;P 500 , after the materials sector.</p>\n<p>Momentum stock screen -- expected sales growth</p>\n<p>Thinking again about financials, they have had plenty of momentum as investors have gained confidence the U.S. economy will continue roaring back from the damage caused by the coronavirus pandemic.</p>\n<p>But revenue growth can be an important driver, especially for individual stock prices over the long term. From here, the financials might not be the best place to look for rapidly rising revenue over the next two years.</p>\n<p>Starting with the 125 momentum stocks held by MTUM, here are the 15 companies expected by analysts polled by FactSet to increase revenue the most over the next two calendar years, with 2021 as the baseline. The figures are in millions of dollars:</p>\n<p>Those are stellar sales-growth numbers -- if the analysts are close to being correct. Many of the stocks are also expensive relative to the expected 2023 sales numbers. In comparison, the <a href=\"https://laohu8.com/S/EMDI\">iShares</a> S&amp;P 500 Growth ETF <a href=\"https://laohu8.com/S/IVW\">$(IVW)$</a> (which tracks the entire S&amp;P 500 Growth Index) trades for 4.2 times estimated 2023 sales.</p>\n<p>Plug Power Inc. <a href=\"https://laohu8.com/S/PLUG\">$(PLUG)$</a> tops the list, with analysts expecting sales to increase to $1.1 billion in 2023. The company said on June 10 it would build a hydrogen-production plant in Camden County, Ga.</p>\n<p><a href=\"https://laohu8.com/S/SNAP\">Snap Inc</a>. (SNAP) CEO Evan Spiegal said recently the company had grown to 500 million active daily users and that almost half of U.S. smartphone users were using Snapchat.</p>\n<p>Novavax Inc. <a href=\"https://laohu8.com/S/NVAX\">$(NVAX)$</a> expects to apply for FDA approval of its coronavirus vaccine during the third quarter.</p>\n<p><a href=\"https://laohu8.com/S/CVNA\">Carvana Co.</a> (CVNA) has been on a tear, with used-car demand spiking in the wake of component shortages for automobile production. The company's sales by units increased 76% in the first quarter from a year earlier.</p>\n<p>Uber Technologies Inc. <a href=\"https://laohu8.com/S/UBER\">$(UBER)$</a> and Lyft Inc <a href=\"https://laohu8.com/S/LYFT\">$(LYFT)$</a> are also expected to ride the economic recovery wave, although analysts expect Lyft to take longer to exceed its pre-pandemic revenue level .</p>\n<p><a href=\"https://laohu8.com/S/PLTR\">Palantir Technologies Inc.</a> (PLTR) rounds out the list. The developer of software used by government defense and intelligence agencies was included in this analysis of meme stocks .</p>\n<p>Earnings</p>\n<p>Some of these companies are still in relatively early growth stages, and aren't expected to achieve full-year profitability until 2023. Here are consensus earnings-per-share estimates for three years:</p>\n<p>Those are very high price-to-earnings ratios based on current stock prices and consensus estimates for 2023. But for rapidly growing companies, earnings typically aren't a priority, which explains why Amazon.com Inc. <a href=\"https://laohu8.com/S/AMZN\">$(AMZN)$</a> always trades at a high P/E. In comparison, the the <a href=\"https://laohu8.com/S/EMEY\">iShares</a> S&amp;P 500 Growth ETF trades for 23.3 times its weighted aggregate consensus earnings estimate for 2023.</p>\n<p>Wall Street's opinion</p>\n<p>Here's a summary of opinion about the 15 companies held by MTUM that analysts expect to grow their revenue the most over the next two years:</p>\n<p>The 12-month price targets may not be useful -- for traders, this is an eternity; it may be a short period for long-term investors looking to profit for years as sales (and hopefully earnings, eventually) compound. It is important to do your own research and form your own opinion about a company's financial health and its ability to remain competitive.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>15 momentum stocks expected to show the best sales growth over the next two years, including Carvana, Tesla and Palantir</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n15 momentum stocks expected to show the best sales growth over the next two years, including Carvana, Tesla and Palantir\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-06-12 12:00</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Several companies on a stock screen have estimated two-year revenue growth of over 100%.</p>\n<p>There are many broad approaches to the stock market for selecting individual companies or groups for investments. Momentum investing -- trying to ride the wave of other investors' sentiment -- is popular for day-traders, especially during the current meme-stock craze. But it can also work over the long term.</p>\n<p>Below is a list of momentum stocks of companies expected to show the strongest sales growth over the next two years.</p>\n<p>Momentum ETF</p>\n<p>To begin with a large group of momentum stocks, we can look at the <a href=\"https://laohu8.com/S/MTUM\">iShares MSCI USA Momentum Factor</a> ETF (MTUM). This is the largest U.S. ETF that follows a momentum strategy, according to Mark Hulbert performance relative to its benchmark, the S&amp;P 500 Growth Index.</p>\n<p>For example, the largest holding of the ETF is Tesla Inc. <a href=\"https://laohu8.com/S/TSLA\">$(TSLA)$</a>, which \"has experienced strong risk-adjusted performance related to the market over the past 12 months,\" according to <a href=\"https://laohu8.com/S/EEME\">iShares</a> (a subsidiary of BlackRock Inc. <a href=\"https://laohu8.com/S/BLK\">$(BLK)$</a>). But shares of Merck &amp; Co. Inc. <a href=\"https://laohu8.com/S/MRK\">$(MRK)$</a> are excluded from MTUM because even though <a href=\"https://laohu8.com/S/EGRW\">iShares</a> considered its 12-month return \"attractive,\" the stock's six-month risk-adjusted return underperformed the benchmark.</p>\n<p>So keeping in mind the weighting by price performance relative to the index, tempered by volatility (going back as much as three years), here are the top 10 holdings of the <a href=\"https://laohu8.com/S/IHPXF\">iShares MSCI</a> USA Momentum Factor ETF:</p>\n<table>\n <tbody>\n  <tr>\n   <td>Company</td>\n   <td>Ticker</td>\n   <td>Share of MTUM</td>\n  </tr>\n  <tr>\n   <td>Tesla Inc.</td>\n   <td>TSLA</td>\n   <td>5.00%</td>\n  </tr>\n  <tr>\n   <td>JPMorgan Chase &amp; Co.</td>\n   <td>JPM</td>\n   <td>4.76%</td>\n  </tr>\n  <tr>\n   <td>Berkshire Hathaway Inc. Class B</td>\n   <td>BRK.B</td>\n   <td>4.58%</td>\n  </tr>\n  <tr>\n   <td>Walt Disney Co.</td>\n   <td>DIS</td>\n   <td>4.48%</td>\n  </tr>\n  <tr>\n   <td>$Bank of America Corp(BAC-N)$.</td>\n   <td>BAC</td>\n   <td>4.29%</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/PYPL\">PayPal</a> Holdings Inc.</td>\n   <td>PYPL</td>\n   <td>3.66%</td>\n  </tr>\n  <tr>\n   <td>Wells Fargo &amp; Co.</td>\n   <td>WFC</td>\n   <td>3.11%</td>\n  </tr>\n  <tr>\n   <td>Applied Materials Inc.</td>\n   <td>AMAT</td>\n   <td>3.00%</td>\n  </tr>\n  <tr>\n   <td>Alphabet Inc. Class C</td>\n   <td>GOOG</td>\n   <td>2.67%</td>\n  </tr>\n  <tr>\n   <td>Alphabet Inc. Class A</td>\n   <td>GOOGL</td>\n   <td>2.45%</td>\n  </tr>\n  <tr>\n   <td>Goldman Sachs Group Inc.</td>\n   <td>GS</td>\n   <td>2.30%</td>\n  </tr>\n  <tr>\n   <td>(FactSet)</td>\n   <td></td>\n   <td></td>\n  </tr>\n </tbody>\n</table>\n<p>Actually, there are 11 stocks listed, as MTUM holds both share classes of Alphabet Inc. Banks and insurers make up half the list, which makes sense because financials have been the second-best performing sector in the S&amp;P 500 , after the materials sector.</p>\n<p>Momentum stock screen -- expected sales growth</p>\n<p>Thinking again about financials, they have had plenty of momentum as investors have gained confidence the U.S. economy will continue roaring back from the damage caused by the coronavirus pandemic.</p>\n<p>But revenue growth can be an important driver, especially for individual stock prices over the long term. From here, the financials might not be the best place to look for rapidly rising revenue over the next two years.</p>\n<p>Starting with the 125 momentum stocks held by MTUM, here are the 15 companies expected by analysts polled by FactSet to increase revenue the most over the next two calendar years, with 2021 as the baseline. The figures are in millions of dollars:</p>\n<p>Those are stellar sales-growth numbers -- if the analysts are close to being correct. Many of the stocks are also expensive relative to the expected 2023 sales numbers. In comparison, the <a href=\"https://laohu8.com/S/EMDI\">iShares</a> S&amp;P 500 Growth ETF <a href=\"https://laohu8.com/S/IVW\">$(IVW)$</a> (which tracks the entire S&amp;P 500 Growth Index) trades for 4.2 times estimated 2023 sales.</p>\n<p>Plug Power Inc. <a href=\"https://laohu8.com/S/PLUG\">$(PLUG)$</a> tops the list, with analysts expecting sales to increase to $1.1 billion in 2023. The company said on June 10 it would build a hydrogen-production plant in Camden County, Ga.</p>\n<p><a href=\"https://laohu8.com/S/SNAP\">Snap Inc</a>. (SNAP) CEO Evan Spiegal said recently the company had grown to 500 million active daily users and that almost half of U.S. smartphone users were using Snapchat.</p>\n<p>Novavax Inc. <a href=\"https://laohu8.com/S/NVAX\">$(NVAX)$</a> expects to apply for FDA approval of its coronavirus vaccine during the third quarter.</p>\n<p><a href=\"https://laohu8.com/S/CVNA\">Carvana Co.</a> (CVNA) has been on a tear, with used-car demand spiking in the wake of component shortages for automobile production. The company's sales by units increased 76% in the first quarter from a year earlier.</p>\n<p>Uber Technologies Inc. <a href=\"https://laohu8.com/S/UBER\">$(UBER)$</a> and Lyft Inc <a href=\"https://laohu8.com/S/LYFT\">$(LYFT)$</a> are also expected to ride the economic recovery wave, although analysts expect Lyft to take longer to exceed its pre-pandemic revenue level .</p>\n<p><a href=\"https://laohu8.com/S/PLTR\">Palantir Technologies Inc.</a> (PLTR) rounds out the list. The developer of software used by government defense and intelligence agencies was included in this analysis of meme stocks .</p>\n<p>Earnings</p>\n<p>Some of these companies are still in relatively early growth stages, and aren't expected to achieve full-year profitability until 2023. Here are consensus earnings-per-share estimates for three years:</p>\n<p>Those are very high price-to-earnings ratios based on current stock prices and consensus estimates for 2023. But for rapidly growing companies, earnings typically aren't a priority, which explains why Amazon.com Inc. <a href=\"https://laohu8.com/S/AMZN\">$(AMZN)$</a> always trades at a high P/E. In comparison, the the <a href=\"https://laohu8.com/S/EMEY\">iShares</a> S&amp;P 500 Growth ETF trades for 23.3 times its weighted aggregate consensus earnings estimate for 2023.</p>\n<p>Wall Street's opinion</p>\n<p>Here's a summary of opinion about the 15 companies held by MTUM that analysts expect to grow their revenue the most over the next two years:</p>\n<p>The 12-month price targets may not be useful -- for traders, this is an eternity; it may be a short period for long-term investors looking to profit for years as sales (and hopefully earnings, eventually) compound. It is important to do your own research and form your own opinion about a company's financial health and its ability to remain competitive.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PLTR":"Palantir Technologies Inc.","SNAP":"Snap Inc","CVNA":"Carvana Co.","TSLA":"特斯拉","PLUG":"普拉格能源"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2142206100","content_text":"Several companies on a stock screen have estimated two-year revenue growth of over 100%.\nThere are many broad approaches to the stock market for selecting individual companies or groups for investments. Momentum investing -- trying to ride the wave of other investors' sentiment -- is popular for day-traders, especially during the current meme-stock craze. But it can also work over the long term.\nBelow is a list of momentum stocks of companies expected to show the strongest sales growth over the next two years.\nMomentum ETF\nTo begin with a large group of momentum stocks, we can look at the iShares MSCI USA Momentum Factor ETF (MTUM). This is the largest U.S. ETF that follows a momentum strategy, according to Mark Hulbert performance relative to its benchmark, the S&P 500 Growth Index.\nFor example, the largest holding of the ETF is Tesla Inc. $(TSLA)$, which \"has experienced strong risk-adjusted performance related to the market over the past 12 months,\" according to iShares (a subsidiary of BlackRock Inc. $(BLK)$). But shares of Merck & Co. Inc. $(MRK)$ are excluded from MTUM because even though iShares considered its 12-month return \"attractive,\" the stock's six-month risk-adjusted return underperformed the benchmark.\nSo keeping in mind the weighting by price performance relative to the index, tempered by volatility (going back as much as three years), here are the top 10 holdings of the iShares MSCI USA Momentum Factor ETF:\n\n\n\nCompany\nTicker\nShare of MTUM\n\n\nTesla Inc.\nTSLA\n5.00%\n\n\nJPMorgan Chase & Co.\nJPM\n4.76%\n\n\nBerkshire Hathaway Inc. Class B\nBRK.B\n4.58%\n\n\nWalt Disney Co.\nDIS\n4.48%\n\n\n$Bank of America Corp(BAC-N)$.\nBAC\n4.29%\n\n\nPayPal Holdings Inc.\nPYPL\n3.66%\n\n\nWells Fargo & Co.\nWFC\n3.11%\n\n\nApplied Materials Inc.\nAMAT\n3.00%\n\n\nAlphabet Inc. Class C\nGOOG\n2.67%\n\n\nAlphabet Inc. Class A\nGOOGL\n2.45%\n\n\nGoldman Sachs Group Inc.\nGS\n2.30%\n\n\n(FactSet)\n\n\n\n\n\nActually, there are 11 stocks listed, as MTUM holds both share classes of Alphabet Inc. Banks and insurers make up half the list, which makes sense because financials have been the second-best performing sector in the S&P 500 , after the materials sector.\nMomentum stock screen -- expected sales growth\nThinking again about financials, they have had plenty of momentum as investors have gained confidence the U.S. economy will continue roaring back from the damage caused by the coronavirus pandemic.\nBut revenue growth can be an important driver, especially for individual stock prices over the long term. From here, the financials might not be the best place to look for rapidly rising revenue over the next two years.\nStarting with the 125 momentum stocks held by MTUM, here are the 15 companies expected by analysts polled by FactSet to increase revenue the most over the next two calendar years, with 2021 as the baseline. The figures are in millions of dollars:\nThose are stellar sales-growth numbers -- if the analysts are close to being correct. Many of the stocks are also expensive relative to the expected 2023 sales numbers. In comparison, the iShares S&P 500 Growth ETF $(IVW)$ (which tracks the entire S&P 500 Growth Index) trades for 4.2 times estimated 2023 sales.\nPlug Power Inc. $(PLUG)$ tops the list, with analysts expecting sales to increase to $1.1 billion in 2023. The company said on June 10 it would build a hydrogen-production plant in Camden County, Ga.\nSnap Inc. (SNAP) CEO Evan Spiegal said recently the company had grown to 500 million active daily users and that almost half of U.S. smartphone users were using Snapchat.\nNovavax Inc. $(NVAX)$ expects to apply for FDA approval of its coronavirus vaccine during the third quarter.\nCarvana Co. (CVNA) has been on a tear, with used-car demand spiking in the wake of component shortages for automobile production. The company's sales by units increased 76% in the first quarter from a year earlier.\nUber Technologies Inc. $(UBER)$ and Lyft Inc $(LYFT)$ are also expected to ride the economic recovery wave, although analysts expect Lyft to take longer to exceed its pre-pandemic revenue level .\nPalantir Technologies Inc. (PLTR) rounds out the list. The developer of software used by government defense and intelligence agencies was included in this analysis of meme stocks .\nEarnings\nSome of these companies are still in relatively early growth stages, and aren't expected to achieve full-year profitability until 2023. Here are consensus earnings-per-share estimates for three years:\nThose are very high price-to-earnings ratios based on current stock prices and consensus estimates for 2023. But for rapidly growing companies, earnings typically aren't a priority, which explains why Amazon.com Inc. $(AMZN)$ always trades at a high P/E. In comparison, the the iShares S&P 500 Growth ETF trades for 23.3 times its weighted aggregate consensus earnings estimate for 2023.\nWall Street's opinion\nHere's a summary of opinion about the 15 companies held by MTUM that analysts expect to grow their revenue the most over the next two years:\nThe 12-month price targets may not be useful -- for traders, this is an eternity; it may be a short period for long-term investors looking to profit for years as sales (and hopefully earnings, eventually) compound. It is important to do your own research and form your own opinion about a company's financial health and its ability to remain competitive.","news_type":1},"isVote":1,"tweetType":1,"viewCount":406,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}